HIIT for VO₂ Max
One or two structured interval sessions a week.
Problem
You want the training input with the strongest all-cause mortality data. Cardiorespiratory fitness — proxied by VO₂ max — is that metric. Zone 2 builds the base. What adds the number at the top?
Solution
One or two structured interval sessions a week. Nothing more.
Three structures that work, on a rower, bike, or treadmill — pick one:
| Protocol | Structure | Target |
|---|---|---|
| Norwegian 4×4 | 4 min hard / 3 min easy × 4 rounds | Heart rate >170 bpm during the hard block (for most adults under 50). |
| 30/15s | 30 sec hard / 15 sec easy × 10–15 | Top of aerobic capacity; easier to hit on a bike. |
| VO₂ hill repeats | 90 sec steep / 2 min easy × 6 | Same physiology as the 4×4 with a scenery change. |
One of these per week is enough for most people. Two is the upper bound for adults also running the § 4.1 strength program. Three is too many — recovery debt and injury risk compound.
170 bpm for 30+ minutes across two workouts a week saw 20%+ HRV gains. That was the cleanest dose-response signal in the whole study (see § 6.2).
Discussion
The Trial 3 data also flagged a second pattern: women in the cohort who had done a structured race (run or bike, >45 minutes) within the prior three years were already near-ceiling on HRV headroom. For them the HIIT dose-response was much smaller; they were better served by strength and recovery work. If your cardiorespiratory ceiling has already been raised by earlier life, the returns to HIIT are smaller.
Two rules I held to:
- Fully warm up before you go hard. 10 minutes easy before the first interval. Most HIIT injuries happen in the first 60 seconds of the first hard block.
- Don't stack HIIT on top of heavy strength day. Put it on its own day, or at minimum the morning of a light strength session. Recovery is the bottleneck, not capacity.
55, cleared for exercise, and new to structured intervals, start with one session a week at submaximal intensity and build up over eight weeks. The >170 bpm target is for adults under 50; scale accordingly.
See Also
- § 6.2 · Cohort 3 Deep Dive — where the dose-response numbers came from
- § 2.4 · Wearable Selection — how to measure the response